Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merus N.V. CS
(NQ:
MRUS
)
54.15
+0.56 (+1.04%)
Streaming Delayed Price
Updated: 9:56 AM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merus N.V. CS
< Previous
1
2
3
Next >
MRUS Stock Earnings: Merus Misses EPS, Misses Revenue for Q2 2024
August 01, 2024
MRUS stock results show that Merus missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 28, 2024
Via
Benzinga
Crude Oil Rises 1%; Verastem Shares Slide
May 24, 2024
Via
Benzinga
Exposures
Fossil Fuels
Expert Ratings for Merus
November 28, 2023
Via
Benzinga
The Latest Analyst Ratings for Merus
October 24, 2023
Via
Benzinga
10 Analysts Have This to Say About Merus
September 14, 2023
Via
Benzinga
Where Merus Stands With Analysts
August 10, 2023
Via
Benzinga
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 24, 2024
Via
Benzinga
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
May 24, 2024
Merus announces interim clinical data on petosemtamab and Keytruda (pembrolizumab) for first-line recurrent/metastatic head and neck squamous cell carcinoma. Early results show promising efficacy with...
Via
Benzinga
Nasdaq Gains 1%; Intuit Shares Plunge
May 24, 2024
Via
Benzinga
Expert Ratings for Merus
July 24, 2023
Via
Benzinga
Analyst Expectations for Merus's Future
June 30, 2023
Via
Benzinga
Where Merus Stands With Analysts
May 18, 2023
Via
Benzinga
Recap: Merus Q1 Earnings
May 04, 2023
Via
Benzinga
Analyst Boosts Merus Price Target As AACR Updates Meaningfully De-Risk Its Head & Cancer Therapy
April 18, 2023
Via
Benzinga
Why Top 4% Biotech Stock, Merus, Just Catapulted To A Record High
May 24, 2024
The company passed investors' bar for success in a study of a head-and-neck cancer treatment.
Via
Investor's Business Daily
Deckers Outdoor Posts Upbeat Earnings, Joins Guardant Health, Ross Stores And Other Big Stocks Moving Higher On Friday
May 24, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 24, 2024
We're diving into the biggest pre-market stock movers that traders need to know about on Friday morning with all of the latest news!
Via
InvestorPlace
MRUS Stock Earnings: Merus Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
MRUS stock results show that Merus beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
The Latest Analyst Ratings for Merus
April 05, 2023
Via
Benzinga
4 Analysts Have This to Say About Merus
March 01, 2023
Via
Benzinga
AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst
September 11, 2023
On Sunday night, AstraZeneca Plc (NASDAQ: AZN) presented the Phase 3 FLAURA2 results evaluating Tagrisso plus chemotherapy versus Tagrisso monotherapy as first-line treatment for patients
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023
August 21, 2023
Via
Benzinga
7 Stocks That Wall Street Analysts Are Loving in May
May 21, 2023
Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love.
Via
InvestorPlace
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday
April 18, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 18, 2023
Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...
Via
Benzinga
Merus' Petosemtamab Abstract Hits Upside Scenario For Overall Response Rate, Duration Of Response: Analyst
April 14, 2023
Via
Benzinga
What To Expect When Merus Presents Petosemtamab Data Update At AACR
April 06, 2023
Via
Benzinga
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 09, 2023
Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.